Pathophysiology and Management of Variceal Bleeding

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Cirrhosis is a leading cause of adult death, often leading to portal hypertension (PH).
• PH causes complications like gastric and esophageal varices, increasing bleeding risk.
• Variceal bleeding is a life-threatening emergency in liver cirrhosis patients.

Purpose of the Study:

• To explain the pathophysiology of cirrhosis and PH in relation to variceal formation.
• To review and compare current treatments for variceal bleeding across different management stages.
• To highlight pharmacological interventions for bleeding prevention and hemostasis.

Main Methods:

• Literature review of cirrhosis pathophysiology and portal hypertension.
• Analysis of current treatment strategies for variceal bleeding (primary prophylaxis, active bleeding, secondary prophylaxis).
• Focus on pharmacological agents for bleeding prevention and hemostasis.

Main Results:

• Pathophysiology of cirrhosis and PH explained, contextualizing variceal development.
• Comparison of treatments across primary prophylaxis, active bleeding, and secondary prophylaxis stages.
• Discussion of drugs for preventing variceal bleeding and achieving hemostasis.

Conclusions:

• Effective management of variceal bleeding requires a multidisciplinary approach.
• Understanding pathophysiology is key to selecting appropriate treatments.
• Pharmacological agents play a crucial role in preventing and managing variceal bleeding in cirrhosis.